T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Crown Holdings
CCK
$12.9B
| $15.8M | ﹤0.01% |
198,984
+36,895
| +23% | +$3.02M |
|
1027
Moog Inc Class A
MOG.A
$13.5B
| $15.7M | ﹤0.01% |
98,217
-1,798
| -2% | -$265K |
|
1028
CONMED
CNMD
$1.49B
| $15.7M | ﹤0.01% |
195,634
-102,704
| -34% | -$9.15M |
|
1029
Bio-Rad Laboratories Class A
BIO
$9.66B
| $15.4M | ﹤0.01% |
44,582
+748
| +2% | +$246K |
|
1030
Magnolia Oil & Gas
MGY
$6.13B
| $15.4M | ﹤0.01% |
594,173
+1,624
| +0.3% | +$35.6K |
|
1031
BWX Technologies
BWXT
$15.6B
| $15.3M | ﹤0.01% |
148,755
-9,499
| -6% | -$850K |
|
1032
F5
FFIV
$23.6B
| $15.2M | ﹤0.01% |
80,292
+811
| +1% | +$150K |
|
|
SAGE
1033
DELISTED
Sage Therapeutics
SAGE
| $15.2M | ﹤0.01% |
811,934
+333,805
| +70% | +$7.7M |
|
1034
UDR
UDR
$12.2B
| $15.1M | ﹤0.01% |
404,709
-4,828
| -1% | -$178K |
|
1035
Supernus Pharmaceuticals
SUPN
$2.74B
| $15.1M | ﹤0.01% |
442,757
-2,559
| -0.6% | -$76.2K |
|
1036
Doximity
DOCS
$4.74B
| $15.1M | ﹤0.01% |
559,826
+2,190
| +0.4% | +$62.4K |
|
1037
Qorvo
QRVO
$8.68B
| $15M | ﹤0.01% |
130,929
+167
| +0.1% | +$18.4K |
|
1038
Lyell Immunopharma
LYEL
$337M
| $15M | ﹤0.01% |
336,574
+4,630
| +1% | +$198K |
|
1039
KBR
KBR
$4.81B
| $15M | ﹤0.01% |
235,101
+4,804
| +2% | +$273K |
|
|
CYBR
1040
DELISTED
CyberArk
CYBR
| $14.9M | ﹤0.01% |
56,262
+49,360
| +715% | +$12.2M |
|
1041
First American
FAF
$7.56B
| $14.9M | ﹤0.01% |
244,302
+1,302
| +0.5% | +$76.9K |
|
1042
Henry Schein
HSIC
$10B
| $14.8M | ﹤0.01% |
195,841
-3,323
| -2% | -$249K |
|
1043
Tapestry
TPR
$25.9B
| $14.5M | ﹤0.01% |
304,774
-13,851
| -4% | -$594K |
|
|
SKX
1044
DELISTED
Skechers
SKX
| $14.4M | ﹤0.01% |
234,558
-1,183
| -0.5% | -$72.2K |
|
1045
First Citizens BancShares
FCNCA
$25.6B
| $14.3M | ﹤0.01% |
8,769
+365
| +4% | +$549K |
|
1046
Toyota
TM
$223B
| $14.2M | ﹤0.01% |
56,532
+1,886
| +3% | +$417K |
|
|
CERE
1047
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $14.2M | ﹤0.01% |
335,357
-385,698
| -53% | -$16.2M |
|
1048
Hormel Foods
HRL
$13.4B
| $14.1M | ﹤0.01% |
404,445
+17,208
| +4% | +$549K |
|
1049
Centrus Energy
LEU
$3.83B
| $14M | ﹤0.01% |
338,250
+46,254
| +16% | +$2.12M |
|
1050
Invesco Senior Loan ETF
BKLN
$6.76B
| $13.9M | ﹤0.01% |
656,100
-4,144,094
| -86% | -$87.5M |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.